[#item_full_content] Three marijuana companies are taking the Drug Enforcement Administration (DEA) to court over restrictions the agency is placing on cannabis businesses under the Trump administration’s federal rescheduling move. Last month, DEA announced it had granted federal registration and protections to hundreds of medical marijuana businesses in line with rescheduling while also issuing new guidance warning  Read More